In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 237 for your search:
Drug:  epirubicin hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: RAD01, EudraCT 2006-003034-15, NCT00936689

2.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: BGSM-74484, NCI-V85-0227

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1586

4.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: NYH-068004-087, NCI-V86-0129

5.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: YALE-HIC-3709, NCI-V86-0094

6.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI
Protocol IDs: POG-8741/42, POG-8741, POG-8742

7.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 85 and under
Sponsor:
Protocol IDs: EORTC-30869

8.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: EORTC-62901

9.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: GEICAM/2006-14, Nº EudraCT 2007-007031-13, NCT00841828

10.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: CDR0000641309, PACT-7, SRSI-PACT-7, EU-20932, NCT00960284

11.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 65 and over
Sponsor: Other
Protocol IDs: GBG 52, 2008-003995-23, NCT01204437

12.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: DLBS1425-0310, NCT01433562

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: EORTC-10920

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MRC-BS07, EU-94028

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: MRC-ST02, EU-94035, NCT00002615

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: GENENTECH-HO648G, NCI-V95-0714

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: DAN-DBCG-94-03, EU-95008

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 15 at initial diagnosis
Sponsor:
Protocol IDs: MRC-LEUK-UKALL-R2, EU-95039

19.

Phase: Phase III
Type: Health services research, Treatment
Status: Completed
Age: 16 to 65
Sponsor: Other
Protocol IDs: CDR0000064834, IBCSG-15-95, EU-96021, NCT00002784

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 74
Sponsor:
Protocol IDs: DAN-DBCG-9505, SBG-94-1, EU-95010

21.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 60
Sponsor: Other
Protocol IDs: CDR0000065151, FRE-FNCLCC-PEGASE03, EU-96032, NCT00002870

22.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: FRE-FNCLCC-GFEA-09, EU-96015, FRE-GFEA-09

23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 18
Sponsor: Other
Protocol IDs: SIOP-MMT-95, EU-96035, NCT00002898

24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor:
Protocol IDs: CNR-012307, EU-95017

25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor:
Protocol IDs: MRC-UKCCCR-AB01, EU-97002, NCT00002953
1     
New Search